CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 215 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $401,691 | -22.9% | 7,414 | -0.2% | 0.17% | -17.3% |
Q1 2024 | $520,777 | -16.6% | 7,428 | -0.7% | 0.20% | -19.2% |
Q4 2023 | $624,338 | +185.1% | 7,478 | +0.6% | 0.25% | +145.1% |
Q3 2023 | $219,006 | -10.6% | 7,434 | -1.0% | 0.10% | -1.9% |
Q2 2023 | $244,846 | -6.9% | 7,506 | +0.4% | 0.10% | -14.0% |
Q1 2023 | $263,010 | -23.5% | 7,474 | -0.5% | 0.12% | -26.7% |
Q4 2022 | $344,017 | -5.2% | 7,508 | +0.1% | 0.16% | -16.7% |
Q3 2022 | $363,000 | +11.0% | 7,501 | -9.9% | 0.20% | +13.8% |
Q2 2022 | $327,000 | +6.9% | 8,321 | 0.0% | 0.17% | +37.0% |
Q1 2022 | $306,000 | -19.3% | 8,321 | 0.0% | 0.13% | -16.4% |
Q4 2021 | $379,000 | +27.6% | 8,321 | 0.0% | 0.15% | +19.7% |
Q3 2021 | $297,000 | -34.3% | 8,321 | -57.2% | 0.13% | +32.3% |
Q1 2021 | $452,000 | – | 19,430 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |